Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07144839 · ClinicalTrials.gov registry record
Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation
A clinical trial of Stillbirth and Placental Insufficiency, sponsored by Oregon Health and Science University.
- Recruiting
- Registry status
- 640
- Enrollment target
- 1
- Study location
NCT07144839: Recruiting study of Stillbirth and Placental Insufficiency, sponsored by Oregon Health and Science University.
NCT07144839 is a study of Stillbirth and Placental Insufficiency that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 640 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07144839, a study of Stillbirth and Placental Insufficiency, is actively recruiting participants, sponsored by Oregon Health and Science University.
- RECRUITING
- Registry status
- 640 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective observational study with the goal of developing and assessing a predictive model of placental insufficiency.
Primary Outcome
The composite is made of the following: stillbirth and neonatal death, severe forms of hypertensive disease, placental abruption, birthweight below the 3rd percentile, umbilical cord arterial pH\<7, and/or placental primary indication for delivery (FGR, oligohydramnios, abnormal fetal testing)
Conditions Studied
Interventions
- OTHER Data Collection Throughout Pregnancy and Delivery
Study Locations (1)
Oregon
- Oregon Health & Science University - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 640 participants |
| Start Date | 2025-09-18 |
| Est. Completion | 2029-06 |
What NCT07144839 shows while recruiting
NCT07144839 is an observational study that tracks outcomes without assigning an intervention. The registered 640 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Stillbirth appearing as the primary indexed condition, and to 1 intervention - of which Data Collection Throughout Pregnancy and Delivery is the first listed.
NCT07144839 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT07144839 about?
NCT07144839 is a clinical study titled "Placental Risk Assessment to CusTomize Individualized Pregnancy Care and Evaluation". This is a prospective observational study with the goal of developing and assessing a predictive model of placental insufficiency.
What is the current status of trial NCT07144839?
This trial is currently recruiting. The enrollment target is 640 participants. The study started on 2025-09-18. Estimated completion is 2029-06.
What conditions does trial NCT07144839 study?
This clinical trial studies the following conditions: Stillbirth, Placental Insufficiency.
What interventions are being tested in trial NCT07144839?
The interventions under investigation include: Data Collection Throughout Pregnancy and Delivery (OTHER).
Who is sponsoring clinical trial NCT07144839?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07144839 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stillbirth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04339699 · 640 participants · NA
NobleStitch EL STITCH Trial is a PFO Comparative Trial
- NCT04979338 · 640 participants · Phase 3
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
- NCT05156398 · 640 participants · Phase 3
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- NCT05930483 · 640 participants · NA
Remotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI